7 episodes

The official podcast of TRC Healthcare, home of Pharmacist’s Letter, Prescriber's Letter, RxAdvanced, and the most trusted clinical resources. Listen in as we discuss current topics impacting medication therapy and patient care. Pharmacist’s Letter is offering CE credit for this podcast. Please log into your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

Medication Talk TRC Healthcare

    • Health & Fitness
    • 4.7 • 18 Ratings

The official podcast of TRC Healthcare, home of Pharmacist’s Letter, Prescriber's Letter, RxAdvanced, and the most trusted clinical resources. Listen in as we discuss current topics impacting medication therapy and patient care. Pharmacist’s Letter is offering CE credit for this podcast. Please log into your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.

    Statin Intolerance

    Statin Intolerance

    TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Joseph Saseen, PharmD, FCCP, FNLA, Associate Dean for Clinical Affairs, Professor, Department of Clinical Pharmacy and Professor, Department of Family Medicine from the Skaggs School of Pharmacy and Pharmaceutical Sciences at the University of Colorado Anschutz Medical Campus about managing statin intolerance. 
    Listen in as they discuss how to evaluate statin-associated muscle pain...and review strategies to help patients take a statin successfully. 
    You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
    Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor HealthAnthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson UniversitySteven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve UniversityJoseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower HealthCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support).
    The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
    Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
    If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 
    Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

    • 32 min
    Managing Nonalcoholic Fatty Liver Disease

    Managing Nonalcoholic Fatty Liver Disease

    TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Kenneth Cusi, MD, FACP, FACE,  Professor of Medicine and Chief of the Division of Endocrinology, Diabetes and Metabolism from The University of Florida about managing nonalcoholic fatty liver disease.
    Listen in as they discuss considerations with managing nonalcoholic fatty liver disease (NAFLD)...including risk factors, screening, and treatment options.
    You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
    Anthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson UniversityDouglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of MedicineCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Cusi reports relevant financial relationships with Echosens, Inventiva, Nordic Pharma, Novo Nordisk, Poxel, Zydus (grants/research support); Ionis, Janssen, Genentech, Gilead, Madrigal, Merck, Novo Nordisk, Pfizer, Poxel, Terns Pharmaceuticals (consultant). The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
    Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
    If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 
    Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

    • 28 min
    Managing Agitation in Dementia

    Managing Agitation in Dementia

    TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Dr. Russ Blackwelder, MD, MDiv, CMD,  Associate Professor and Director of Geriatric Education from the MUSC Department of Family Medicine and Co-Medical Director from The Village at Summerville about managing agitation in patients with dementia.
    Listen in as they discuss practical strategies for managing agitation in patients with dementia...and clarify pros and cons of various medications.
    You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
    Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor HealthAnthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson UniversityCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science UniversityNone of the speakers have anything to disclose. 
    Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
    If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 
    Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

    • 27 min
    Meds for End-of-Life Care

    Meds for End-of-Life Care

    TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Dr. Dwight Blair, MD, Inpatient Palliative Care Consultant from Lower Cape Fear Lifecare and New Hanover Regional Medical Center about meds for end-of-life care.
    Listen in as they discuss unique med considerations for patients at the end of life...and how to help fine-tune meds for these patients.
    You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
    Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor HealthAnthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson UniversityCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science UniversityNone of the speakers have anything to disclose. 
    Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
    If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 
    Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

    • 24 min
    New Heart Failure Guidelines

    New Heart Failure Guidelines

    TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with two distinguished experts about new heart failure guidelines. 
    Carolyn Lam, MBBS, PhD, FRCP, Professor at Duke-NUS Medical School and a Senior Consultant at the National Heart Centre SingaporeSteven E. Nissen, MD, MACC, the Chief Academic Officer at the Heart and Vascular Institute and the Lewis and Patricia Dickey Chair in Cardiovascular Medicine Professor of Medicine at the Cleveland Clinic Lerner School of Medicine at Case Western Reserve UniversityListen in as they discuss new guidelines for managing heart failure with reduced ejection fraction (HFrEF)...and put this new guidance in perspective.
    You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
    Andrea Darby Stewart, MD, Associate Director, Family Medicine Residency at Honor HealthAnthony A. Donato, Jr., MD, MHPE, Associate Program Director, Internal Medicine from the Reading Health System, and Professor of Medicine at the Sidney Kimmel Medical College at Thomas Jefferson UniversityCraig D. Williams, PharmD, FNLA, BCPS, Clinical Professor, Department of Pharmacy Practice at the Oregon Health and Science UniversityFor the purposes of disclosure, Dr. Carolyn Lam reports relevant financial relationships with Bayer, Roche Diagnostics (grants/research support); Abbott, Actelion, Alleviant Medical, Allysta Pharmaceuticals, Amgen, AnaCardio AB, Applied Therapeutics, AstraZeneca, Bayer, Boehringer Ingelheim, Boston Scientific, Cytokinetics, Darma Inc., EchoNous Inc, Impulse Dynamics, Ionis Pharmaceuticals, Janssen, Merck, Novartis, Novo Nordisk, Roche Diagnostics, Sanofi, Siemens Healthcare Diagnostics, Us2.ai (advisory board/steering committee/executive committee); Us2.ai (stock shareholder); Us2.ai (non-executive director).
    Dr. Steven Nissen reports a relevant financial relationship with AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Esperion, Medtronic, Novartis, Pfizer, Silence Therapeutics (grants/research support).
    The other speakers have nothing to disclose. All relevant financial relationships have been mitigated.
    Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
    If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 
    Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

    • 30 min
    Homeopathy

    Homeopathy

    TRC Editor, Dr. Lori Dickerson, PharmD, FCCP talks with Chelsey McIntyre, PharmD, Managing Editor of TRC’s Natural Medicines about homeopathy.
    She’ll help clear up confusion about what homeopathic products are...and aren’t...and how they compare to supplements. 
    You’ll also hear practical advice from panelists on TRC’s Editorial Advisory Board:
    Reid B. Blackwelder, MD, FAAFP, Associate Dean of Graduate and Continuing Medical Education at East Tennessee State UniversityAndrea Darby-Stewart, MD, Associate Director, Family Medicine Residency at Honor HealthDouglas S. Paauw, MD, MACP, Professor of Medicine at the University of Washington School of MedicineJoseph Scherger, MD, MPH, Family Physician, Primary Care 365, Eisenhower HealthNone of the speakers, panelists, or staff you’ll hear in this episode have anything to disclose. 
    Pharmacist’s Letter offers CE credit for this podcast. Log in to your Pharmacist’s Letter account and look for the title of this podcast in the list of available CE courses.
    If you’re not yet a Pharmacist’s Letter subscriber, find out more about our product offerings at trchealthcare.com. 
    Follow or subscribe, rate, and review this show in your favorite podcast app. You can also reach out to provide feedback or make suggestions by emailing us at ContactUs@trchealthcare.com. 

    • 22 min

Customer Reviews

4.7 out of 5
18 Ratings

18 Ratings

Asciguy ,

Homeopathy

100% Bogus. FDA says you can rip people off with the products and they don’t care.

You Might Also Like

Mike Corvino, PharmD, BCPS, BCACP, CDCES and Cole Swanson, PharmD, CDCES
Eric Christianson, PharmD; Pharmacology Expert and Clinical Pharmacist
TRC
The Curbsiders Internal Medicine Podcast
JAMA Network
American Academy of Family Physicians